Click here to watch this video on YouTube
A leading pharmaceutical manufacturer specialising in asthma inhalers has transformed its in-line testing operations thanks to an automated quality control solution developed by Mitsubishi Electric and leading system integrator Optimal Industrial Automation. The innovative system uses two Selective Compliance Articulated Robot Arms (SCARA) and system-matched components, such as a MELSEC-iQ platform PLC and MAPS SCADA software.
The fully automated quality control solution increased leak detection rates for in-line pharmaceutical gas analysis during inhaler production by 30 times, significantly reducing manufacturing cost and waste generation.
Delivering quality medicaments is a must for pharmaceutical manufacturers, as it ensures that the treatment is safe and therapeutically effective. When producing metered dose inhaler (MDI) canisters, typically used for respiratory drug delivery for people suffering from Asthma, it is essential that all products released into the market can generate a suitable aerosol of a drug formulation. To do so, it is necessary to fill the canisters with an optimum level of liquefied gas under pressure, then test for gas leaks and dispose of any faulty canisters.
While detecting gas propellant leaks in MDI canisters is of utmost importance, conventional, non-automated methods suffer from a number of limitations. Automation can address these issues and help pharmaceutical manufacturers to improve their profitability. In particular automated testing helps move away from manual, off-line leak inspections – which slow down production and reduce overall volumes. Embracing in-line or at-line testing means operators do not need to physically collect samples and can achieve a rapid uplift in productivity.